Trinity Capital

TRIN

Market cap $1.05B

PHOENIX , Oct. 14, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $130 million in growth capital to Candel Therapeutics, Inc. (Nasdaq: CADL) ("Candel"), a clinical-stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight cancer. Candel Therapeutics is developing a clinical pipeline of off-the-shelf cancer treatments that aim to empower a patient's own immune system to fight cancer.

Trinity Capital Inc. remains a Buy despite the recent BDC sector selloff, supported by strong fundamentals, consistent dividends, and record NAV growth. Trinity Capital reported Q2 2025 investment income up 27%, NII up 30%, and NAV up 36% year-over-year, with low non-accruals and robust portfolio diversification. Fears of lower interest rates are overblown for TRIN, as its funding costs would fall and portfolio structure limits negative NII impact, supporting future earnings.

Company funds $471 million of investments in the third quarter of 2025 PHOENIX , Oct. 9, 2025 /PRNewswire/ -- Trinity Capital Inc.  (Nasdaq: TRIN) ("Trinity Capital" or the "Company"), a leading alternative asset manager, today announced a portfolio update for the third quarter and first three quarters of 2025. Trinity Capital originated $773 million of new commitments in the third quarter of 2025, bringing new commitments for the first three quarters of 2025 to $1.5 billion.

PHOENIX , Oct. 8, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of Paul D'Agrosa as Managing Director of Life Sciences, based in Denver, Colorado. Mr. D'Agrosa will help expand the Company's Life Sciences business to new markets across the U.S., bringing with him more than a decade of experience in loan origination, business development, and relationship management.

CHARLOTTE, N.C.--(BUSINESS WIRE)--Town Lane and Trinity Capital Advisors Announce Uptown Charlotte Office Acquisition.

PHOENIX , Oct. 7, 2025 /PRNewswire/ -- Trinity Capital Inc.  (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced that it will release its third quarter 2025 financial results at 8:00 a.m. ET on Wednesday, November 5, 2025.

The BDC sector has been hammered. The discounts have become deep almost across the board. The question is whether to enter now, or is the risk still too high that it will end up being a 'catching a falling knife' moment?

Investors love dividend stocks and ETFs, especially those with ultra-high mega yields, because they provide a substantial passive income stream and offer significant total return potential.

BDCs are in trouble. It is not only interest rates but also other factors such as tight dividend coverage levels, debt-saturated balance sheets, and spread compression that introduce risks. In my view, many BDCs will very likely cut dividends and burn NAV. In the article, I elaborate on two BDCs, which are headed in the opposite (positive) direction.

PHOENIX , Sept. 22, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $45 million in growth capital to Rapid Micro Biosystems (Nasdaq: RPID) ("Rapid Micro"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products.